(Q39511788)

12 September 2017

title

A Comparison of Serum Immunoglobulins from Patients with Non-neoplastic Prostates and Prostatic Carcinoma (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57217-1

7 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57217-1

7 November 2022

author name string

F. A. Deture

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A81321

7 November 2022

S. L. Deardourff

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A81321

7 November 2022

H. E. Kaufman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A81321

7 November 2022

Y. M. Centifanto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A81321

7 November 2022

language of work or name

English

0 references

publication date

1 October 1978

1 reference

full work available at URL

12 September 2017

https://api.elsevier.com/content/article/PII:S0022534717572171?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57217-1

https://api.elsevier.com/content/article/PII:S0022534717572171?httpAccept=text/plain

7 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57217-1

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2957217-1

7 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57217-1

7 November 2022

1 reference

12 September 2017

volume

120

1 reference

12 September 2017

issue

4

1 reference

12 September 2017

page(s)

435-437

1 reference

Immunologic considerations of carcinoma of the prostate

12 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57217-1

Immunotherapy for prostatic cancer. Previous and prospective considerations

7 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57217-1

On the incidence of carcinoma of the prostate

7 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57217-1

Relationships of immunology to cancer: a review

7 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57217-1

Serum immunoglobulins in genitourinary malignancies

7 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57217-1

Serum proteins in patients with benign and malignant diseases of the prostate

7 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57217-1

Serum immunoglobulins in patients with prostate cancer

7 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57217-1

Occult Carcinoma of the Prostate: an Oversight of Immune Surveillance—A Working Hypothesis

7 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57217-1

Changes in human serum immunoglobulin levels with age and sex

7 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57217-1

Longitudinal changes in serum immunoglobulin levels in older humans

7 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57217-1

7 November 2022

Identifiers

0 references

1 reference